2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.
For decades, the United States and the United Kingdom have enjoyed a special relationship that crosses political, economic, and military lines. But, the two nations also share a similar comradery in the Life Sciences arena, and prominent biotech hubs like the BioHealth Capital Region and Philadelphia showcase that connection.
Over the past nine months, more than $7 billion in federal funding has poured into the BioHealth Capital Region aimed at the battle against COVID-19 and has shown a spotlight on the broad impact biopharma life science companies and academic institutions are making in the fight against the pandemic.
The state of Maryland is the global epicenter of vaccine research and development. This has never been more evident than right now as scores of Maryland companies have risen to the global challenge of developing the first approved vaccine for SARS-CoV-2.
The Top Biotech Companies That are Hiring – June 2020 June 9, 2020 Despite the uncertainty created by the COVID-19 pandemic, companies across the BioHealth Capital Region (BHCR) continue to [….]
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Companies
The Top Five Life Science Companies in Maryland For Career Growth and Promotions
GSK Expands biomanufacturing Apprenticeship Program in Maryland with Montgomery College
Secretary Kelly Schulz
GSK Biopharm Site Director, Craig Malzahn addressing BioBuzz attendees at recruiting event
